Begin main content

Reports

We found 6590 result(s)

2020 CADTH Symposium

Event Date: April 19, 2020 - April 21, 2020
Result type: Events

Join us in Toronto for the 2020 CADTH Symposium. Connect with Canadian and international experts in the objective assessment and evaluation of health technologies for three days of education, information sharing, and networking. Mark your calendar: 2020 CADTH Symposium
April 19 to 21, 2020
Sheraton Centre Toronto
Toronto, On...

Evidence-to-Action: Accessing Mental Health Support Outside of a Therapist’s Office: iCBT for Major Depression and Anxiety Disorders

Event Date: November 27, 2019
Result type: Events

Internet-delivered cognitive behavioural therapy (iCBT) is a treatment option for people living with depression or anxiety disorders. This event will provide the opportunity to increase awareness around existing iCBT work in Canada and will facilitate a conversation between various stakeholders across the country. Join us online or in person as...

CADTH Medical Device and Drug Portfolio Information Sessions

Event Date: November 25, 2019
Result type: Events

These sessions will be presented in English and are available in person or via live broadcast. There is no charge to attend, but advance registration is required. Registration closes November 19, 2019. CADTH Medical Device Portfolio Information Session 10:00 a.m. to 12:00 p.m. EST Health technology assessment (HTA) plays a key role in decisi...

teduglutide (Revestive)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: teduglutide
Indications: Short Bowel Syndrome (SBS), pediatrics

  • Brand Name: Revestive
  • Manufacturer: Shire Pharmaceuticals Ireland Limited
  • Project Number: SR0606-000
  • Project Status: Active
  • Submission Type: New Indication

lanadelumab (Takhzyro)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: lanadelumab
Indications: Hereditary angioedema, prevention

  • Brand Name: Takhzyro
  • Manufacturer: Shire Pharma Canada ULC
  • Project Number: SR0618-000
  • Project Status: Active
  • Submission Type: New

tildrakizumab (Ilumya )

Last Updated: November 11, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: tildrakizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Ilumya
  • Manufacturer: Sun Pharma Canada
  • Project Number: SR0624-000
  • Project Status: Active
  • Submission Type: New

cyclosporine (Verkazia)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cyclosporine
Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)

  • Brand Name: Verkazia
  • Manufacturer: Santen Inc.
  • Project Number: SR0615-000
  • Project Status: Active
  • Submission Type: New

safinamide (Onstryv)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: safinamide
Indications: Parkinson's disease

  • Brand Name: Onstryv
  • Manufacturer: Valeo Pharma Inc.
  • Project Number: SR0617-000
  • Project Status: Active
  • Submission Type: New

sodium zirconium cyclosilicate (Lokelma)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: sodium zirconium cyclosilicate
Indications: Hyperkalemia, adults

  • Brand Name: Lokelma
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SR0612-000
  • Project Status: Active
  • Submission Type: New